Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

RA is an autoimmune disease where the immune system mistakenly attacks the lining of joints, causing inflammation and potential joint damage. Treatment goals for RA include reducing inflammation and ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

The weight-loss benefits of GLP-1 medications like Ozempic, Wegovy, and Zepbound are widely known. However, as more and more people take these medications, there appear to be other benefits, such as ...

Signs of immune system aging appear years before rheumatoid arthritis takes hold, offering new hope for early diagnosis and ...

Dana Orange’s research may help predict flares, provide precise drug targets, and enable interventions that block symptoms ...

Medically reviewed by Stella Bard, MD People with rheumatoid arthritis (RA) are at a higher risk for infections, including ...

Rheumatoid arthritis (RA) is on the rise. In fact, a recent global study in Lancet Rheumatology predicts that RA cases are expected to increase by more than 80 percent over the next 26 years. And ...

Medically reviewed by Amy Kwan, PT Gentle exercises can ease stiffness and improve strength and flexibility for people with ...

Researchers have developed a nanoparticle-based platform for treating rheumatoid arthritis (RA) that comprises ceria nanoparticles (Ce NPs) immobilized onto mesenchymal stem cell-derived nanovesicles ...